You are here

Complex Regional Pain Syndrome G90.50 337.21


synonyms:CRPS, Reflex Sympathetic Dystrophy (RSD), causalgia, minor causalgia, major causalgia, mimocausalgia, pseudocausalgia, algodystrophy, algoneurodystrophy, posttraumatic dystrophy, Sudeckís atrophy, and sympathetically maintained pain syndrome, shoulder-hand syndrome.



  • 337.21 (reflex sympathetic dystrophy of the upper limb)
  • 337.22 (reflex sympathetic dystrophy of the lower limb)

CRPS Etiology / Epidemiology / Natural History

  • an exaggerated response to injury of an extremity manifested by: 1) intense or unduly prolonged pain, 2) vasomotor disturbances, 3) delayed functional recovery, and 4) various associated trophic changes. 
  • Pathophysiology: unknown. sympathetic nerve disorder vs hypersensitivity to catecholamines vs local inflammation vs neural injury.
  • Upper Extremity: associated with distal radius fractures.
  • Lower Extremity: symptoms in the lower extremity are more refractory to intervention than those in the upper extremity.
  • Knee:the most common inciting incident is injury or operation to the patella(64%).  Patellar osteoporosis is the most common x-ray change and is typically seen within 2-4 weeks. 
  • Women/men = 3-4/1
  • Risk Factors: women, smoking, age 30-50.
  • Outcomes are better the sooner CRPS is diagnosed and treated.

CRPS Anatomy

CRPS Clinical Evaluation

  • Pain or allodynia/hyperalgesia not limited to the territory of a single peripheral nerve and disproportionate to inciting event. Pain may be described as burning, searing, throbbing, tearing.
  • Edmea, changes in skin blood flow.
  • Skin temperature changes.
  • May progress from painful/hot/swollen to painful/cold/atrophic to stiff/atrophic.
  • Allodynia = pain caused by a normally nonpainful stimulus
  • Hyperpathia = perception of pain that is delayed and extends beyond the normal nerve distribution.

CRPS Xray / Diagnositc Tests

  • Xray indicated to rule out other causes. Generally normal initially. Advanced stages may show subchondral osteopenia / bone demineralization.
  • Bone scans: Generally show increased periarticular uptake in each phase, decreased flow has been reported in the acute setting. Specificity of 75% to 98% and a sensitivity of only 50% . (Teasdall RD, Foot Ankle Clin 1998;3:485).
  • MRI: no proven diagnostic value.
  • Phentolamine (total dose 25-35 mg), an alpha1-adrenergic sympathetic blocking agent with a very short duration of action has been proposed as a diagnostic test for CRPS. (Raja SN, Anesthesiology 1991;74:691)
  • EMG/NCV: Generally normal. Consider to evaluate for associated nerve lesion. EMG is painful, especially in CRPS patients and may worsen their condition.
  • Sympatholytic Drug Administration: patients can be given injectable or oral sympatholytic drugs (IV phentolamine) to determine if they have sympathetically maintained pain (SMP) or sympathetically independent pain (SIP).

CRPS Classification / Treatment

  • Acute: <3 months. Warm, red, edematous extremity; aching, burning pain; intolerance have to cold; altered sweat pattern; joint stiffness without any significant effusion; hyperesthetic skin; no fixed joint contractures. Xray: normal, +/- abnormal uptake on bone scan.
  • Dystrophic: 3-6 months. Cool, cyanotic, edematous extremity; shiny, hyperesthetic skin; fixed contractures; fibrotic changes occur in the synovium. Xray: subchondral osteopenia; +/- abnormal uptake on bone scan.
  • Atrophic: >6months. Loss of hair, nails, skin folds; fixed contractures; muscle wasting. Xray: bone demineralization.
  • Type I= formerly termed "reflex sympathetic dystrophy", occurs with no definable nerve lesion. TypeII=formerly termed "causalgia", cases with a defialbe nerve lesion.
  • No proven treatment algorithm.
  • Best managed with multidisciplinary team: orthopaedic surgeon, anesthesiologist, physiatrist, physical therapist, occupational therapist, and psychiatrist.
  • Physical therapy: control edema, prevent joint contracture, passive and active ROM, contrast baths, TENS, iontophoresis; beneficial in all stages of CRPS.
  • Effective Medications: prednisone, amitryptyline, gabapentin, phenytoin, amlodipine besylate, clonidine, calcitonin.
  • Bretylium intravenous regional sympathetic block: affected extremity is exsanguinated and placed under 300-mm Hg tourniquet control for 20 min. 0.5% lidocaine and bretylium 1.5 mg/kg is infused into a vein. (Hord AH, Anesth Analg 1992;74:818)
  • Sympathetic local anesthetic blockade. Generally lidocaine or bupivacaine introduced via a needle into the paravertebral sympathetic ganglia. (O'Brien SJ, AJSM 1995 23: 655)
  • Continuous epidural anesthesia. Epidural block anesthesia instituted with an indwelling catheter with continuous passive motion, manipulation (as necessary), stimulation of muscles, and alternating hot and cold soaks over @ 4 days. (Cooper DE, JBJS 1989;71A;365)
  • Alpha-adrenergic blocking agents: Phenoxybenzamine and prazosin (Muizelaar JP, Clin Neurol Neurosurg 1997;99:26)
  • Calcium channel blockers: Nifedipine (Muizelaar JP, Clin Neurol Neurosurg 1997;99:26)
  • Bisphosphonates: consider for long-standing CRPS with osteopenia. (Adami S, Ann Rheum Dis. 1997;56:201)
  • Also consider: anticonvulsant (gabapentin), oral beta blocker (propranolol), antiarrhythmic (mexiletine).
  • Narcotic: little restorative value. Can result in drug dependence without improving function.
  • Beware of social issues (liability, workers compensation, disability) that may provide a financial disincentive for patients to report improvement.

CRPS Associated Injuries / Differential Diagnosis

  • Factitious Syndromes: SHAFT(sad, hostile, anxious, factitious, tenacious), Munchausen)
  • Soft-tissue Infection
  • Osteitis
  • Nonunion
  • Rheumatoid arthritis
  • Polyneuropathy / neuritis
  • Tumor

CRPS Complications

  • Chronic pain
  • Joint contractures / stiffness
  • Muscle atrophy
  • Osteopenia

CRPS Follow-up Care

  • 80% will show significant improvement if diagnosed within one year. 50% will have long-term morbidity if diagnoses after 1 year.

CRPS Review References

  • Cooper DE, DeLee JC: Reflex sympathetic dystrophy of the knee.  J Am Acad Orthop Surg 1994;2:79-86.
  • Hogan CJ, JAAOS 2002;10:281
  • Griffin LY, Essentials of Musculoskeletal Care 3rd edition, AAOS, 2005


The information on this website is intended for orthopaedic surgeons.  It is not intended for the general public. The information on this website may not be complete or accurate.  The eORIF website is not an authoritative reference for orthopaedic surgery or medicine and does not represent the "standard of care".  While the information on this site is about health care issues and sports medicine, it is not medical advice. People seeking specific medical advice or assistance should contact a board certified physician.  See Site Terms / Full Disclaimer